
|Articles|April 15, 2005
Symposium tackles difficult issues of glaucoma
Cardiovascular medicine has provided a road map that ophthalmology can follow in risk assessment.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA approves Amneal Pharmaceuticals' cyclosporine ophthalmic emulsion 0.05%
2
Avisi Technologies treats first patient in SAPPHIRE trial for glaucoma
3
Iolyx Therapeutics and Laboratoires Théa enter into agreement over ILYX-002 for the treatment of OSD
4
Belite Bio releases topline results from phase 3 DRAGON trial of Tinlarebant for STGD1
5















































.png)


